Does EVOLOCUMAB Cause Hepatic enzyme increased? 264 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Hepatic enzyme increased have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.2% of all adverse event reports for EVOLOCUMAB.
264
Reports of Hepatic enzyme increased with EVOLOCUMAB
0.2%
of all EVOLOCUMAB reports
1
Deaths
26
Hospitalizations
How Dangerous Is Hepatic enzyme increased From EVOLOCUMAB?
Of the 264 reports, 1 (0.4%) resulted in death, 26 (9.8%) required hospitalization.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which EVOLOCUMAB Alternatives Have Lower Hepatic enzyme increased Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE